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Abstract
Background: Despite progress to expand access to HIV testing and treatment during pregnancy in Kenya, gaps still remain in
prevention of mother-to-child transmission of HIV (PMTCT) services. This study addresses the need for effective and scalable
interventions to support women throughout the continuum of care for PMTCT services in low-resource settings. Our research
team has successfully implemented the HIV Infant Tracking System (HITSystem), a Web-based, system-level intervention to
improve early infant diagnosis (EID) outcomes.
Objective: This study will expand the scope of the HITSystem to address PMTCT services to bridge the gap between maternal
and pediatric HIV services and improve outcomes. This paper describes the intervention development protocol to adapt and pilot
an HITSystem version 2.0 to assess acceptability, feasibility, and preliminary PMTCT outcomes in Kenya.
Methods: This is a 3-year intervention development study to adapt the current HITSystem intervention to support a range of
PMTCT outcomes including appointment attendance, antiretroviral therapy (ART) adherence, hospital deliveries, and integration
of maternal and pediatric HIV services in low-resource settings. The study will be conducted in 3 phases. Phase 1 will elicit
feedback from intervention users (patients and providers) to guide development and refinement of the new PMTCT components
and inform optimal implementation. In Phase 2, we will design and develop the HITSystem 2.0 features to support key PMTCT
outcomes guided by clinical content experts and findings from Phase 1. Phase 3 will assess complete PMTCT retention (before,
during, and after delivery) using a matched randomized pilot study design in 2 hospitals over 18 months. A total of N=108
HIV-positive pregnant women (n=54 per site) will be enrolled and followed from their first PMTCT appointment until infant
HIV DNA Polymerase Chain Reaction testing at the target age of 6 weeks (<7 weeks) postnatal.
Results: Funding for this study was received in August 2015, enrollment in Phase 1 began in March 2016, and completion of
data collection is expected by May 2019.
https://www.researchprotocols.org/2019/6/e13268/
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Conclusions: This protocol will extend, adapt, and pilot an HITSystem 2.0 version to improve attendance of PMTCT appointments,
increase ART adherence and hospital-based deliveries, and prompt EID by 6 weeks postnatal. The HITSystem 2.0 aims to improve
the integration of maternal and pediatric HIV services.
Trial Registration: ClinicalTrials.gov NCT02726607; https://clinicaltrials.gov/ct2/show/NCT02726607 (Archived by WebCite
at http://www.webcitation.org/78VraLrOb)
International Registered Report Identifier (IRRID): DERR1-10.2196/13268
(JMIR Res Protoc 2019;8(6):e13268) doi: 10.2196/13268
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Introduction
Background
Despite impressive progress to expand access to HIV testing
and treatment during pregnancy in Kenya [1,2], gaps still remain
in achieving comprehensive prevention of mother-to-child
transmission of HIV (PMTCT) services. Despite widespread
access (77% to 80%) to the highly efficacious Option B+
antiretroviral therapy (ART), the current rate of perinatal
transmission in Kenya is estimated at 8.3% to 11.5% [3-5]. Late
and inconsistent attendance at antenatal appointments,
suboptimal ART adherence during pregnancy and breastfeeding,
high rates of unskilled deliveries, and high dropout throughout
the PMTCT cascade are among the barriers to eliminating
perinatal HIV infection in Kenya [6].
Although Kenyan national guidelines encourage 4 or more
antenatal care (ANC) visits [7], an estimated 11.2% to 57.6%
[8,9] attend all 4 appointments, with 95% of women attending
at least 1 ANC appointment [2]. Attendance of all PMTCT
appointments is crucial for monitoring treatment, progression
of pregnancy, and managing risk of transmission. Poor
medication adherence during pregnancy and breastfeeding
compromises the efficacy of ART to prevent HIV transmission.
In Kenya, approximately 15% to 20% of pregnant and
postpartum women are less than 95% adherent to their ART
regimen [10,11]. Since 2012, hospital deliveries are free of
charge; yet, nationwide, only 61% of births are facility-based
[9], with HIV positive women more likely to have a nonfacility
delivery than HIV uninfected women [12]. Home deliveries
among HIV positive women miss opportunities for timely infant
ART prophylaxis, which can reduce the risk of perinatal
transmission by up to 47% in low-resource settings [13-16].
Infants of mothers with suboptimal drug adherence are more
vulnerable to perinatal HIV transmission [17,18], thus infant
ART prophylaxis remains a critical safeguard.
The PMTCT cascade necessitates that women successfully
navigate a series of steps including maternal HIV counseling
and testing, initiation and monitoring of ART, delivery care,
infant ART and cotrimoxazole prophylaxis, linkage into early
infant diagnosis (EID) care for their HIV-exposed infants, and
linkage to lifelong HIV care for themselves. Although HIV
testing during ANC is high (93.1%) [2], rates of retention after
successful linkage to PMTCT are low. In a study conducted by
Ayuo et al [19], 31.9% of pregnant women enrolled in PMTCT
were disengaged from care for more than 30 consecutive days
https://www.researchprotocols.org/2019/6/e13268/
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(thus missing a medication refill appointment) at least once
during their pregnancy, with 22.5% of all patients disengaged
during the critical phase immediately before delivery. These
data reflect a setting with an active outreach program for
retention and thus may underestimate attrition in facilities
without outreach programs. After delivery, an additional 19.3%
to 45% of infants are lost to follow-up [20,21]. At least one
quarter of infants are enrolled late in EID, missing the target
for EID testing by 6 weeks of age [22]. Consequently, a
significant proportion of mother-infant pairs receive incomplete
services [23].
Mobile phone and Web-based technologies provide viable
solutions to individual and system-level challenges in the
delivery of HIV services in Kenya and other African countries.
Short message service (SMS) text messaging interventions have
improved attendance at ANC appointments [24,25], medication
adherence and viral suppression [15,16], and postpartum
PMTCT retention [26]. Tailoring health messages to the
individuals within the target population increases participant
retention and is critical to the success of mHealth interventions
[27-29]. Most mHealth interventions for EID have focused on
lab-specific efficiency [30], patient-specific adherence, or
retention support [31], whereas the HIV Infant Tracking System
(HITSystem) mHealth intervention was the first to link
laboratory, clinical, and patient stakeholders in one integrated
system [32].
This study addresses the need for effective and scalable
interventions to coordinate the continuum of care for PMTCT
services in low-resource settings to maximize retention and
minimize infant HIV infection. Our research team has
successfully implemented a Web-based mHealth intervention
called the HITSystem, which utilizes available technology
(internet and texting) to improve communication and
accountability between EID stakeholders to optimize outcomes
for HIV-exposed infants [33,34]. The HITSystem is unique as
a system-level mHealth intervention combining SMS outreach
to mothers of HIV-exposed infants and algorithm-based
dashboard alerts to prompt provider (maternal and child health
[MCH]/HIV and laboratory) action, and it demonstrated
significant reductions in turnaround times for Polymerase Chain
Reaction (PCR) test results (2.3 weeks faster), mother
notification of results (1.3 weeks faster), younger infant age at
ART initiation (7.6 weeks younger), and higher retention
throughout the complete 18-month EID cascade of care (85%
vs 60%; aOR 3.7 (2.5 to 5.5); P<.001) when compared with
standard EID services [32]. This proposal responds to requests
JMIR Res Protoc 2019 | vol. 8 | iss. 6 | e13268 | p. 2
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from hospital administrators and health care providers to expand
the scope of the HITSystem to include antenatal PMTCT
services and to bridge the current gap between maternal and
pediatric HIV services. Thus, this intervention development
protocol will adapt and pilot an HITSystem version 2.0 that
prospectively tracks and supports HIV positive women through
their pregnancy and delivery, linking them to EID follow-up at
birth (initial HITSystem 1.0) to facilitate linked mother-infant
data and retention. We will assess the acceptability, feasibility,
and preliminary impact on PMTCT retention of the HITSystem
2.0 intervention.

Study Overview
This is a 3-year intervention development study to adapt and
pilot test an extension of the current HITSystem intervention
to support a range of PMTCT outcomes including retention in
ANC, ART adherence, hospital deliveries, and integration of
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maternal and pediatric HIV services in low-resource settings.
The study will be conducted in 3 phases (Figure 1). Phase 1 is
designed to elicit feedback from intervention users (patients
and providers) to guide development of the new PMTCT
components and inform optimal implementation at the
intervention site. Phase 2 involves the technical design and
development of HITSystem 2.0, a new iteration of the
HITSystem to support key PMTCT outcomes (appointment
attendance, ART medication adherence, hospital-based delivery,
and linkage to EID). Phase 2 development will be guided by
clinical content experts and findings from Phase 1. This involves
close collaboration with programmers and system users to refine
the interface and customize options. Phase 3 will pilot the
HITSystem 2.0 in 1 hospital over an 18-month period and
compare targeted PMTCT outcomes with those at a matched
control hospital.

Figure 1. Study phases—an iterative process of qualitative research and HIV Infant Tracking System (HITSystem) 2.0 design, development, and
refinement, which precedes the HITSystem 2.0 pilot and evaluation.

Methods

Informed consent was conducted with all participants before
study engagement.

Phase 1: Formative Research

Analyses for Focus Group and Key Informant Interview
Data

Phase 1 seeks to understand optimal HITSystem SMS text
messaging strategies. We draw on the Information Processing
Communication Theory [35-37], which identifies the conditions
that encourage people to actively attend to health messages, to
guide questions regarding text message content and timing. We
will recruit HIV positive pregnant and postpartum women who
are/were enrolled in PMTCT care at the intervention site to
participate in 3 focus groups to elicit (1) strategic
communication and customization of SMS text messages to
motivate target behaviors while protecting confidentiality, (2)
barriers to patient retention and ART adherence, and (3)
strategies for mobile phone outreach and alternatives for patient
follow-up. Focus groups will include n=8 women, with 2 of the
3 focus groups including HIV-positive pregnant women (second
and third trimester) and the third including HIV-positive
postpartum women (2 to 16 weeks), thus representing a range
of gestational and postpartum periods. In addition, key informant
interviews will be conducted with all staff engaged in PMTCT
services (antenatal, maternity, postnatal, laboratory, pharmacy,
and mentor mothers; approximately n=8) at the intervention
site to strategize optimal HITSystem 2.0 implementation, given
PMTCT provider capacity and existing systems for patient flow.
In addition to notetaking, with participants’ consent, the focus
groups and interviews will be digitally recorded. Participants
will receive 500 Kenyan Shillings (approximately US $5) in
appreciation of their time. The research protocol was reviewed
and approved by IRB at the Kenya Medical Research Institute
in Nairobi, Kenya, and the University of Kansas Medical Center.
https://www.researchprotocols.org/2019/6/e13268/
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Audio files will be translated and transcribed in English, coded,
and analyzed. In total, 2 study team members will independently
code data for a priori (preferences for health messaging,
potential barriers to retention and ART adherence, alternative
strategies for patient follow-up, and provider recommendations
for optimal implementation) and emergent themes. Through
consensus, we will develop a codebook with typical exemplars
for each theme, noting the frequency and distribution of themes
within the larger topic areas. Summarized themes will directly
inform HITSystem 2.0 development in Phase 2.

Phase 2: Intervention Development
HITSystem 1.0 is currently in use in multiple health facilities
in Kenya. The primary goals of the HITSystem 1.0 are to (1)
improve EID and clinical management of HIV-exposed infants
and (2) facilitate early ART initiation for HIV positive infants
[33,34,38,39]. The HITSystem is accessed on the Web using a
computer or tablet, with mobile broadband modems that respond
to a cellular signal. The primary components include (1)
provider alerts to complete time-sensitive interventions, (2)
real-time communication of PCR laboratory results to hospitals
to reduce turnaround time, (3) persistent follow-up for timely
ART initiation among HIV-positive infants, and (4) retention
in EID care via SMS text messaging and/or patient tracing.
The HITSystem 2.0 intervention will (1) utilize electronic
prompts to notify PMTCT providers and program managers
when action is required to support timely services, patient
JMIR Res Protoc 2019 | vol. 8 | iss. 6 | e13268 | p. 3
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retention and adherence, and linkage to EID once infants are
born [33,34] and (2) send SMS text messages to HIV-positive
pregnant women’s mobile phones with the aim to motivate
adherence to medication, remind women of ANC appointments
and medication refills, and prompt preparation for a hospital
delivery.

HIV Infant Tracking System 2.0 Intervention
Specifications
Clear reporting of intervention components and implementation
strategies is needed for meaningful application in practice or
testing in research [40,41]. The entry point into the HITSystem
2.0 will be the first PMTCT appointment for women previously
diagnosed with HIV or newly confirmed HIV positive during
antenatal HIV screening. Actions include automated prompts
to PMTCT providers, prompts to central laboratory technicians
who process viral load (VL) samples, and SMS texts to patients

driven by national algorithms for optimal PMTCT care (Table
1). Automated electronic prompts to providers will persist as
Web-based dashboard alerts until addressed. Automated SMS
texts are sent to HIV-positive pregnant women as cues to action;
women can select the preferred content and frequency for
one-way ART adherence text messages at the time of
enrollment. This is one of the first interventions to target
adherence support messages during pregnancy, thus texting
options (content and frequency) will be informed by Phase 1
formative research, and actual preferences will be assessed by
this pilot study. Community health care workers can reach out
to patients who miss services and/or do not respond to SMS
text messages or calls to encourage retention. The HITSystem
2.0 will integrate PMTCT and EID services through 1
coordinated system-level intervention; this will permit
longitudinal follow-up of mother-infant pairs to assess PMTCT
outcomes.

Table 1. HITSystem 2.0 intervention components. Expected timing, dose, and target of alerts and SMS (short message service) texts to providers and
HIV positive pregnant women.
Actors

Actions

Dosea

Timing

Target

Hospital-based providers; Algorithm-driven elecproviders
tronic alerts

When PMTCTb service late/miss- Avg=8 per mom, range=0 to PMTCT quality: complete
14+
PMTCT retention (pregnaning (enrollment-infant EIDc link)
cy to EID link)

Lab-based providers; lab Algorithm-driven electechs
tronic alerts

When receipt of VLd sample or
VL results delayed

Avg=1 per mom, range=02+

PMTCT efficiency: reduced
turn-around time for key
PMTCT services

HIV-positive pregnant
women

Appointment reminders (2 days
before appointment); adherence
reminders (daily, weekly, biweekly, monthly); facility-based delivery reminders (4 and 2 weeks be-

Avg=4 per mom, range=08+; avg=20 per mom,
range=0-245+; avg=2 per
mom, range=2 to 2

PMTCT quality and
PMTCT efficiency

Algorithm-driven electronic SMS text messages

fore EDDe)
a

Dose represents anticipated study averages and ranges only, assuming one alert per alert type per pregnancy. Actual dose will depend on client-specific
factors such as gestational age at enrollment, adherence to PMTCT guidelines and scheduled services, and frequency preferences for adherence reminders.
b

PMTCT: prevention of mother-to-child transmission of HIV.

c

EID: early infant diagnosis.

d

VL: viral load.

e

EDD: estimated due date.

Process for Phase 2 Development
We will employ the 4D’s process to define, design, develop,
and deploy the intervention [42]. The clinical algorithms and
portions of the system development will be designed before
completion of Phase 1, but focus group and interview findings
will customize and refine critical aspects of the 4D’s process,
incorporating input from Kenya’s current PMTCT treatment
guidelines and user feedback regarding strategic messaging,
patient and provider barriers, and strategic implementation. The
iterative process of Phases 1 and 2 will enhance the design and
development by ensuring a user-friendly, robust, interactive,
and secure software system to increase engagement, retention,
and quality PMTCT outcomes.

https://www.researchprotocols.org/2019/6/e13268/
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Phase 3: Trial Intervention
Trial Design
We will employ a matched, randomized pilot study design in 2
government hospitals with comparable resources, patient
volume, and basic patient characteristics. One hospital will be
randomized to receive the HITSystem 2.0 intervention and the
other hospital will maintain standard of care PMTCT services.
An extended 18-month implementation period will allow 9
months to reach the sample size requirement of n=54 at each
hospital and another 9 months to ensure complete prospective
outcome data from the first PMTCT appointment in pregnancy
until the infant’s first HIV DNA PCR test result is determined.
This follow-up period will assess complete retention throughout
PMTCT services, ART adherence, and rates of infant HIV
transmission. We will also collect retrospective PMTCT
outcome data from each hospital for the 18 months before
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implementation to facilitate pre- and postcomparisons at the
same facility.
Satisfaction interviews with HITSystem 2.0 users (HIV positive
women and providers) will inform barriers to use that can be
targeted either through future strategic refinement of the design
or collaboration with key partners to address constraints beyond
the scope of this intervention.

Study Sites and Setting
This study will be conducted in 2 government hospitals with
similar provider-patient ratios and staffing structure, Kapsabet
Hospital and Bungoma Hospital, both in western Kenya.
Eligibility criteria for these hospitals include government
funding; the current provision of PMTCT, EID, and ART
services; at least one dedicated provider managing PMTCT
services; and maintenance of individual-level patient files.
Kapsabet Hospital serves a catchment area of approximately
91,000 people [43], has an average monthly EID volume of 10,
and an average infant HIV transmission rate of 2.7% [44].
Bungoma Hospital serves a catchment area of approximately
92,412 people [43], has an average monthly EID volume of 18,
and an average infant HIV transmission rate of 4.2% [44]. These
hospitals serve less transient local populations, making them
ideal pilot sites to adapt and modify the HITSystem 2.0 for the
primary outcome of complete PMTCT retention.

Randomization
As a system-level intervention, it is neither feasible nor
acceptable to randomize participation at the individual level.
The hospital to receive the intervention will be determined by
random assignment at the beginning of the study, using a random
number generator program. The principal investigator and
research staff will be blind to the process of assigning the sites.

Participant Eligibility
All HIV-positive pregnant women presenting for their first
PMTCT appointment at the intervention and control site will
be eligible for enrollment in the study. Women at the
intervention site must also own or have reliable access to a
mobile phone.

Procedures
Participants at both sites will receive PMTCT services guided
by the Kenyan national guidelines [7]. At the time of PMTCT
enrollment (first visit), all eligible women will be informed
about the study by the clinical staff, and written informed
consent for participation, including a review of hospital records
documenting PMTCT services, will be obtained by a trained
hospital staff member.
Training of Hospital and Study Staff
Key hospital personnel (PMTCT and maternity nurses and
mentor mothers) will be trained by employing hands-on data
entry scenarios tailored to the specific capacity in which they
will utilize the HITSystem 2.0. During the first weeks of
implementation, the trained research assistant (RA) will work
closely to ensure thorough understanding and accurate
independent use of the HITSystem 2.0 and will be available
throughout the study to retrain or assist in system-related
https://www.researchprotocols.org/2019/6/e13268/
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problem solving. The RA will be based in the MCH department
with PMTCT providers to monitor and support fidelity to
intervention implementation and timely data entry into the
HITSystem 2.0. The US-based HITSystem team will remotely
review the entered data to identify any challenges or systematic
errors to be addressed. This is the same training and
implementation process successfully employed for the
HITSystem pilot [33] and cluster randomized trial to evaluate
EID outcomes [32]. Training at the control site will be limited
to assessing participant eligibility, conducting informed consent,
and administering the baseline survey. Nurses and mentor
mothers directly involved in PMTCT service provision will
conduct these research tasks. All research and clinical staff
involved in the study will be trained on procedures to ensure
participant confidentiality and secure data storage.
Baseline surveys will be conducted at the initial PMTCT
enrollment visit at both intervention and control sites for all
eligible women. In addition to the basic demographic
information captured in routine care at both hospitals (age and
number of children), questions will assess (1) knowledge and
perceived importance of attendance at scheduled appointments;
ART before, during, and after delivery; consequences of poor
adherence; and infant testing, (2) motivation and self-efficacy
to complete the targeted behaviors (eg, attendance, medication
adherence, plan for delivery, and prompt EID enrollment) using
scaled and Likert responses, (3) assessment of depression
symptoms (6 questions to assess frequency of symptoms
between 0 to 7 days a week) and risk for intimate partner
violence (3 screening questions to facilitate counseling referral),
and (4) male partner involvement. Study staff will enter
completed paper surveys in Excel 2016 (version 1708).
PMTCT service utilization will be documented in the patient
file and relevant PMTCT-related facility registers (intervention
and control) as required by the Kenyan Ministry of Health. At
the intervention hospital, a new record will be created in the
HITSystem 2.0 during PMTCT enrollment and will be updated
at each subsequent visit, including mobile phone number(s) and
residence tracing information. Prospective clinical data from
the mother-infant pair will be captured in the HITSystem 2.0
to track medication adherence, appointment attendance, delivery
outcomes, and postpartum infant prophylaxis data, automating
provider alerts and SMS text messages to participants as
indicated. Any information that is not captured in the HITSystem
at the time of the patient’s visit (owing to workflow,
connectivity, or other challenges) will be updated as soon as
possible after the visit, referencing any relevant paper-based
patient and facility records needed. All relevant data to measure
the targeted PMTCT outcomes will be entered and maintained
in the HITSystem 2.0.
At the control site, paper-based patient files and facility
registries are the primary record-keeping source for PMTCT
data. A study staff member will visit the control site quarterly
to review clinical records to document and update PMTCT
services received by women enrolled in the study. Multiple
sources will be cross-referenced to collect standard of care data
at the control hospital: (1) pregnant women/mothers’ medical
records, (2) hospital ANC registry book, (3) pharmacy ART
JMIR Res Protoc 2019 | vol. 8 | iss. 6 | e13268 | p. 5
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registry, (4) maternity registry, and (5) HIV-exposed infant
registry.

Prevention of Mother-to-Child Transmission of HIV
Appointment Attendance

HITSystem 2.0 user satisfaction will be assessed with
semistructured interviews to solicit feedback on usefulness and
acceptability of the content and frequency of the targeted SMS
text messages, patient tracing efforts, and other
recommendations to improve the intervention. Participants
(n=35) will be purposively selected to include variation among
women with complete/incomplete retention, low/high ART
adherence, and facility/home deliveries. Interviews will be
conducted in the language they prefer (Swahili or English) once
study participation is complete. We will also conduct interviews
with providers and hospital administrators to better understand
the strengths and limitations of the HITSystem 2.0
implementation, its integration with the current HITSystem 1.0,
and suggestions for improvement. Remuneration for interview
participation and the analysis plan for qualitative data will be
the same as described in Phase 1. Interviews will not be
conducted at the control site as they did not experience the
intervention.

We will measure the proportion of mothers who attended all
scheduled ANC appointments, documenting late (>7 days past
scheduled date) and missing (>14 days past scheduled date)
attendance. The number of possible appointments will vary on
gestational age at PMTCT enrollment; thus we will measure
the median number of visits, the proportion who received the
recommended 4 or more appointments, and the proportion
enrolled by the recommended 14 weeks gestation.

Fidelity Assurance Procedures
Standard operating procedures were developed for each step of
the study process to standardize training, enrollment, and all
data collection procedures. As it is Web-based, any modification
or corrections to the HITSystem are instantly applied across all
users. HITSystem entries are routinely reviewed to ensure
completeness and appropriate utilization of the comments
section. Study personnel will make quarterly visits to the control
site to cross-reference enrollment records with patient files and
the relevant PMTCT-related facility registers and to review
informed consent documents and surveys for accuracy,
completeness, and secure storage.

Primary Outcome: Complete Prevention of
Mother-to-Child Transmission of HIV Retention
The primary outcome is complete PMTCT retention, measured
from the first PMTCT appointment until the infant’s first HIV
test, which is targeted at 6 weeks of age. The aggregate measure
of complete retention—calculated as retention before delivery,
at delivery, and after delivery—will be dichotomously coded
as complete or incomplete retention. Complete retention is
defined as maternal ART initiated (if not already on ART at the
time of pregnancy), all scheduled PMTCT appointments
attended, hospital-based delivery, and HIV DNA PCR testing
by 6 weeks (<7 weeks) postnatal.

Secondary Outcomes
Duration of Prevention of Mother-to-Child Transmission
of HIV Retention
We will estimate the duration (number of weeks) of PMTCT
retention for each participant by subtracting the last date of
documented service engagement from the date of enrollment.
This will allow comparisons between total time retained in
PMTCT services between groups and identify when (antenatal,
delivery, or early postnatal) disengagement from PMTCT most
often occurs.

https://www.researchprotocols.org/2019/6/e13268/
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Viral Load Suppression
We will document the proportion of pregnant women who had
a VL sample collected during pregnancy: 6 months after ART
initiation for those diagnosed during ANC or within the past 6
months for those already established on ART, in accordance
with national guidelines. We will abstract data on VL from the
HITSystem 2.0 (intervention) and the patient file and laboratory
records (control) to assess the proportion with VL tests taken,
the turn-around time (TAT) for return of results, and the
proportion with suppressed VL results (defined as<1000 viral
copies/ml) during pregnancy.

Medication Adherence
As VL is still not consistently collected during pregnancy, we
will rely on other indicators of adherence including self-report
of missed doses in the 7 days before appointment (prescribed
vs taken) and pill counts conducted by relevant providers
(dispensed vs returned). Adherence data will be entered in the
HITSystem 2.0 at each appointment. We will calculate the
proportion of patients who report >95% adherence to doses
prescribed (7-day self-report) and pill count.
Hospital delivery will be estimated from the proportion of
pregnant mothers who deliver at a health facility. Women who
do not deliver at the study hospital will be contacted within 2
weeks of their estimated due date to check on their progress,
document location of birth, and encourage prompt return to the
facility for postpartum and postnatal care. EID enrollment will
be measured using the proportion of HIV-exposed infants tested
by 6 weeks of age (<7 weeks).
Infant and maternal mortality will be reported separately, noting
all available data on date and cause of death. A future study will
utilize a design with a longer follow-up period and larger sample
size to adequately evaluate perinatal transmission of HIV.

Power and Sample Size
The required sample size was calculated to compare differences
in proportions of complete PMTCT retention for the intervention
(p1) and control (p2). We estimated complete retention by
combining available retention data from Kenya for each phase:
antenatal retention (68%) [19], hospital-based deliveries (61%)
[36], and postnatal retention for HIV-exposed infants within 12
weeks (54.9% [21] to 80.7% [20]; average 67%). Recognizing
that these estimates do not represent cumulative risk for the
same individuals, we conservatively estimate complete PMTCT
at the control site to be 20%. Our EID pilot data showed that
retention doubled at 9 months with retention rates as high as
94.2% [33]. Using a midrange between differences achieved
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from published studies and our own pilot study, we
conservatively estimate complete retention of 47% for
HITSystem 2.0 participants. A sample size of 108 (54
intervention and 54 control participants) is needed to achieve
80% power to detect a significant difference in the proportion
of complete PMTCT retention with chi-square tests (goodness
of fit test: contingency table) with an effect size of 0.27 and a
2-tailed alpha of .05. Accounting for the proportion with mobile
phone utilization, and 1.5% maternal mortality [45] and 3.7%
[46] perinatal mortality, we estimate n=70 eligible participants.
During Phase 3 enrollment, we plan to enroll n=54 of the n=70
eligible PMTCT patients per hospital. On the basis of our initial
HITSystem pilot where <1% of women declined, we anticipate
high participation.

Statistical Analyses
To examine the baseline participant and facility characteristics,
we will calculate descriptive statistics including proportions for
categorical variables and means (SD) or median (interquartile
range) for continuous variables [47]. For the primary outcome,
chi-square tests will be used to compare the proportion with
complete PMTCT retention between groups [48]. We will
explore correlations between complete PMTCT retention and
possible predictors (eg, knowledge, motivation to complete
care, maternal HIV disclosure, perceived benefit of ART,
maternal depression, and risk of intimate partner violence) using
Phi, point-biserial, or Spearman rho statistics depending on the
measurement level of each predictor [49]. Analytic models will
control for significantly different preintervention covariates
across conditions and hospitals, clustered observations (eg, time
nested within setting), and gestational age as it impacts the
eligible/recommended number of appointments or services.
For secondary analyses, Kaplan-Meier curves will illustrate
differences in the duration of PMTCT retention before, during,
and after delivery, accounting for the woman’s eligible period
of engagement (based on the timing of enrollment and
accounting for premature infant or maternal mortality). We will
then identify time periods when meaningful decreases in
PMTCT retention occur, using Cox proportional-hazard
regression for survival analyses (ie, retention), if all assumptions
are met [50]. Known variables associated with HIV service
retention (age, disclosure status, educational level, and number
of children [22,51,52]) and those correlated (P<.10) will then
be included in a generalized linear mixed model to identify a
parsimonious list of predictors.
Using chi-square tests, we will compare the proportion of
pregnant women (1) attending all scheduled PMTCT
appointments (4 or more PMTCT visits and late or missed
visits), (2) tested for VL (VL sample collected, results returned,
and detectible VL values), (3) delivery at the hospital, (4)
enrolling in EID (dried blood spot sample collected by <7
weeks), and (5) have an infant diagnosed with HIV, between
intervention and control sites. The median number of PMTCT
appointments, median gestational week at first PMTCT
appointment, and median TAT for VL results will be calculated
and compared using Mann Whitney U tests. Although
medication adherence documentation at the control site
(typically described as poor, fair, or good) will not permit direct
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comparison, the proportion of pregnant women at the
intervention site with >95% adherence will be described.
Participant preferences for the content and frequency of SMS
text messages for medication adherence support will also be
described. P values will be adjusted (using Tukey correction)
for multiple tests, where appropriate. Quantitative data will be
analyzed using Statistical Application Software (SAS) version
9.4.

Results
We are actively enrolling participants and collecting data at the
intervention and control sites. Only formative data have been
analyzed and the HITSystem has been adapted. There are no
planned interim analyses of the primary outcome. No analyses
comparing intervention versus control outcome data have been
conducted at this time.

Discussion
Previous HITSystem pilot data and studies have demonstrated
significant success in improvement of EID outcomes particularly
in improving the efficiency and quality of key EID outcomes
[32-34,38]. Leveraging the improved linkage of health facilities,
mother-infant pairs, and laboratories in the context of EID, the
HITSystem 2.0 (PMTCT) will expand the current Web-based
platform to bridge the gap between maternal and pediatric HIV
services. Outcomes at each step of the PMTCT cascade will be
analyzed, and specific challenges will be identified.
This study will design and implement the HITSystem 2.0
through formative qualitative research, intervention development
using the 4Ds process, and a pilot implementation period as
described above. It will also provide user satisfaction data by
highlighting the HITSystem 2.0’s usefulness, acceptability,
challenges, and recommendations to improve the intervention.
The proposed HITSystem 2.0 will integrate maternal and infant
HIV services in one system-level, Web-based intervention that
will provide linked, prospective data for mother-infant pairs,
which has been identified as a problematic gap in the current
system. The findings of this study will refine the HITSystem
2.0 intervention, particularly tracking and utilization of
challenging measures such as medication adherence and
antenatal VL results to enhance system performance and
implementation strategies in a larger scale efficacy trial.
Although this intervention will focus on health system
improvement to enhance quality of care for women and infants
in the facility setting, the study will not directly target PMTCT
uptake, which would require community-based outreach. Given
that intervention site data will be tracked via the HITSystem
whereas control site data will be captured via disparate
paper-based registries and patient files, there may be
discrepancies in data quality and documentation of services
rendered between control and intervention sites; all efforts will
be made to capture any available data at control sites to
minimize this limitation. As the study design and
implementation evolve, we anticipate that eHealth technologies
in the study regions will likewise evolve and influence the
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standard of PMTCT care. These external factors will be
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documented and accounted for in the design and analyses.
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